Ironwood Pharmaceuticals (IRWD) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Ironwood Pharmaceuticals (IRWD) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.56 Bn | 197.57 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 181.34 Bn | 178.16 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.55 Bn | 56.37 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.32 Bn | 49.19 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.32 Bn | 31.01 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.24 Bn | 29.95 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 30.17 Bn | 30.17 Bn | 1.16 Mn | 722.67 Mn |
| 10 | Ironwood Pharmaceuticals | 671.59 Mn | 592.47 Mn | - | 165.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.24 Mn |
| Mar 31, 2026 | 164.61 Mn |
| Dec 31, 2025 | 163.06 Mn |
| Sep 30, 2025 | 162.68 Mn |
| Jun 30, 2025 | 162.43 Mn |
| Mar 31, 2025 | 161.81 Mn |
| Dec 31, 2024 | 160.21 Mn |
| Sep 30, 2024 | 160.02 Mn |
| Jun 30, 2024 | 159.74 Mn |
| Mar 31, 2024 | 158.96 Mn |
| Dec 31, 2023 | 156.35 Mn |
| Sep 30, 2023 | 156.13 Mn |
| Jun 30, 2023 | 156.03 Mn |
| Mar 31, 2023 | 155.35 Mn |
| Dec 31, 2022 | 154.03 Mn |
| Sep 30, 2022 | 153.32 Mn |
| Jun 30, 2022 | 153.18 Mn |
| Mar 31, 2022 | 155.12 Mn |
| Dec 31, 2021 | 162.04 Mn |
| Sep 30, 2021 | 163.41 Mn |